• AZD0156 Workflow for ATM Kinase Research

  2026-08-18

  Build a controlled DNA damage response workflow around AZD0156, from stock preparation and target-engagement assays to combination studies with double-strand break–generating treatments. The guide emphasizes selective ATM biology, orthogonal readouts, assay controls, and practical troubleshooting for cancer therapy research.

• Brefeldin A Workflows for ER–Golgi Research

  2026-08-18

  Brefeldin A helps researchers connect ER–Golgi trafficking defects with ER stress, secretion changes, cytoskeletal remodeling, and apoptosis. This practical guide covers dose planning, endothelial assay adaptation, cancer-cell applications, controls, and troubleshooting for reproducible BFA experiments.

• WY-14643 (Pirinixic Acid): PPARα Research Guide

  2026-08-17

  WY-14643, also called Pirinixic Acid, is a selective PPARα agonist used to investigate lipid metabolism regulation, inflammation, and insulin sensitivity enhancement. Product specifications report an IC50 of 10.11 µM for human PPARα, while preclinical studies support PPARα-linked protection against inflammatory and pyroptotic injury.

• TRIM21–ERK1/2 Signaling in Pituitary Adenomas

  2026-08-16

  Liu and colleagues identify TRIM21 as a context-dependent regulator of ERK1/2 signaling, pituitary adenoma proliferation, and dopamine-agonist resistance. Their combination of CRISPR screening, biochemical studies, animal models, and NanoBiT-based drug screening nominates TRIM21 suppression—and Quisinostat among the identified compounds—as a strategy for restoring treatment sensitivity.

• GRK Control of Biased M1 Receptor Signaling

  2026-08-15

  This 2025 study uses dynamic BRET assays to define how GRK2/3 and GRK5/6 differentially regulate M1 muscarinic receptor coupling to G proteins and β-arrestin 2. Its BQCA results show that allosteric modulation can alter concentration-effect relationships, providing a mechanistic framework for studying acetylcholine receptor signaling and cognitive function modulation.

• BRCAness Predicts Olaparib Sensitivity in Mesothelioma

  2026-08-15

  Borchert et al. linked homologous recombination repair gene-expression patterns and BAP1-associated BRCAness to olaparib sensitivity in malignant pleural mesothelioma models. The study supports molecular stratification of mesothelioma and provides a rationale for testing PARP inhibition with cisplatin, while leaving the clinical predictive value of the signature to be validated.

• PKM2 inhibitor (compound 3k): Assay Guide

  2026-08-14

  A scenario-based guide to using PKM2 inhibitor (compound 3k), SKU B8217, in viability, proliferation, cytotoxicity, and immunometabolism assays. It connects product formulation and potency data with practical controls, dose-response design, interpretation limits, and vendor-selection criteria.

• AICAR Phosphate: AMPK Assay Workflows

  2026-08-14

  AICAR phosphate (Acadesine) provides a practical pharmacological probe for AMPK-linked apoptosis, with a defined B-CLL response and mitochondrial readouts. This guide translates that cancer-research workflow into carefully bounded choroid plexus and hypoxia assays while emphasizing controls, dosing logic, and reproducibility.

• Crizotinib Hydrochloride in ALK Research

  2026-08-13

  Crizotinib hydrochloride is an ATP-competitive ALK kinase inhibitor that also targets c-Met and ROS1. Its defined kinase activity, formulation profile, and compatibility with tumor assembloid workflows support cancer biology research, while patient-derived models help expose microenvironment-dependent limits on drug response.

• EdU Imaging Kits (Cy5): Practical Workflow

  2026-08-13

  EdU Imaging Kits (Cy5) provide a click-chemistry method for labeling DNA synthesis during the S phase, with readouts suitable for fluorescence microscopy and flow cytometry. This guide explains setup, controls, and troubleshooting while noting that EdU incorporation is not, by itself, a complete measure of cell-cycle progression or proliferation rate.

• Acetylcysteine: Redox and Mucus Research Guide

  2026-08-12

  Acetylcysteine, also called N-acetyl-L-cysteine (NAC), supplies cysteine for glutathione biology and can disrupt mucoprotein disulfide bonds. This guide links its mechanism to oxidative stress pathway modulation, respiratory disease models, hepatic protection research, and Huntington’s disease research while separating evidence-backed findings from workflow recommendations.

• Nanoplastic–Cadmium Apoptosis via IP3R/Ca2+/STAT3

  2026-08-12

  A 2026 Toxicology study shows that combined polystyrene nanoplastic and cadmium exposure damages intestinal models through an IP3R/Ca2+/STAT3 signaling axis. Using C. elegans, Caco-2 cells, and pathway-directed inhibitors, the authors connect calcium mobilization with endoplasmic reticulum stress and apoptosis, providing a mechanistic framework for combined-pollutant toxicology.

• Live-Dead Cell Staining Kit I for Translational Oncology

  2026-08-11

  A mechanistic and strategic guide to using Calcein AM/PI fluorescence to validate treatment response, distinguish membrane failure from broader cell-death biology, and strengthen translational oncology decisions.

• Obacunone, Akt/p53 Signaling, and Ferroptosis

  2026-08-10

  A 2025 study shows that obacunone suppresses ovarian cancer growth by promoting ferroptosis and altering the Akt/p53 axis. Using cell and xenograft models, the investigators connected reduced Akt phosphorylation, enhanced p53 expression, glutathione depletion, GPX4 loss, and ACSL4 induction with ferroptotic tumor-cell injury.

• T0070907: Practical PPARγ Antagonist Workflows

  2026-08-09

  T0070907 enables controlled interrogation of PPARγ transcription, adipogenesis, macrophage inflammation, and cancer-associated cell-cycle phenotypes. This workflow-focused guide shows how to separate receptor-dependent activity from compound-related artifacts and translate RXRα/PPARγ findings into reproducible assays.

457 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page